NCT04985916 - ET-01 in Subjects With Lateral Canthal Lines, LCL-210 | Biotech Hunter

Enrollment

280

Participants

Timeline

Start Date

July 19, 2021

Primary Completion Date

February 8, 2024

Study Completion Date

February 8, 2024

Conditions

Lateral Canthal Lines, LCLCrow's Feet

Interventions

BIOLOGICAL

Vehicle

topical liniment without investigational product

BIOLOGICAL

botulinum toxin, Type A

ET-01 topical liniment

Trial Locations (19)

10075

Eirion Research Site, New York

19073

Eirion Research Site, Newtown Square

19341

Eirion Research Site, Exton

20769

Eirion Research Site, Glenn Dale

23502

Eirion Research Site, Norfolk

29615

Eirion Research Site, Greenville

33137

Eirion Research Site, Miami

33180

Eirion Research Site, Aventura

33401

Eirion Research Site, West Palm Beach

33486

Eirion Research Site, Boca Raton

40241

Eirion Research Site, Louisville

48038

Eirion Research Site, Clinton Township

55112

Eirion Research Site, New Brighton

60654

Eirion Research Site, Chicago

70124

Eirion Research Site, New Orleans

75093

Eirion Research Site, Plano

77056

Eirion Research Site, Houston

85255

Eirion Research Site, Scottsdale

92121

Eirion Research Site, San Diego